Lab guide · Neuropeptides
What Is N-Acetyl Semax Amidate? Modified Semax Analogue Peptide Research Overview
What is N-Acetyl Semax Amidate? It is Semax with an acetyl group on the N-terminus and an amide on the C-terminus, Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH2. This guide covers the chemistry of the two end caps, what is established about terminal capping in general, and what has not been shown for this particular analogue.
Key takeaways
- N-Acetyl Semax Amidate has the Semax sequence MEHFPGP with both termini capped, formula C39H54N10O10S and a mass of about 855.0 g/mol, 41 Da above Semax.
- N-terminal acetylation can block DPP-IV and aminopeptidase cleavage in some peptides, but protection is not universal.
- No published study was found that compares this analogue with Semax, so its stability and activity are unproven.
- Evidence about Semax itself belongs to the parent compound and cannot be transferred to the capped form.
What is N-Acetyl Semax Amidate?
So, what is N-Acetyl Semax Amidate? Semax is the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro, an ACTH(4-7) fragment joined to a Pro-Gly-Pro tail; it is covered in What is Semax. N-Acetyl Semax Amidate (NA-Semax-NH2) keeps that sequence but replaces the free amine with an acetamide and the free carboxylic acid with a primary amide. It is a chemical derivative, and there is no evidence base specific to it.
Research use only. This overview summarises published laboratory and animal research. Baltic Peptides supplies this compound for in-vitro and preclinical research by qualified researchers; it is not a medicine and is not for human or veterinary use.
Chemical structure and specifications
| Property | Semax | N-Acetyl Semax Amidate |
|---|---|---|
| Sequence | H-MEHFPGP-OH | Ac-MEHFPGP-NH2 |
| Formula | C37H51N9O10S | C39H54N10O10S |
| Average mass | 813.9 g/mol | 855.0 g/mol |
| Monoisotopic mass | 813.348 Da | 854.375 Da |
| Terminal charges | N-terminal amine (+), C-terminal carboxylate (−) | Both removed |
I confirmed the formulas and masses from the sequence. Acetylation adds C2H2O (+42.011 Da) and amidation replaces OH with NH2 (−0.984 Da), a net +41.03 Da. The caps remove two charges, which changes polarity, retention time and possibly membrane behaviour. No CAS number has been assigned to the capped form, according to the supplier product page.
Discovery and research history
Terminal capping is a long-standing medicinal-chemistry strategy, and acetyl and amide caps appear in many peptide drugs. Semax itself came out of Russian neuropeptide research and is an approved medicine in Russia but not in the EU or US, according to the supplier product page.
N-Acetyl Semax Amidate is a research-market analogue. The sources reviewed contain no original discovery paper for it, so its history is that of Semax plus a generic chemical modification.
What terminal capping does, and does not, show
What is established in general
Blocking the N-terminus can protect peptides from DPP-IV and aminopeptidases. For example, N-terminal acetylation protects GLP-1-(7-34)-amide from DPP-IV degradation: the N-terminally blocked Ac-GLP-1-(7-34)-amide was not degraded in the presence of DPP-IV over at least two hours, while retaining cAMP- and insulin-releasing capacity.
What is not general
Protection is not guaranteed. In a classic study of acetylated peptides, acetylation slowed breakdown but the protection of larger peptides was less reliable, and 72% of acetylated bradykinin was still hydrolysed after 1 hour (Wallace (1992)). Capping can also change receptor interaction. For this analogue, neither effect has been measured in the sources reviewed.
Main research areas
- Stability comparisons: plasma, serum and enzyme-incubation assays against Semax.
- Structure-activity work: effects of removing terminal charges on receptor interaction.
- Analytical method development: using the +41 Da shift to confirm both caps by mass spectrometry.
- Parent-compound research: Semax itself is studied in rodent models of neuroprotection and BDNF signalling, see the Semax article.
What published studies actually show
| Evidence type | What is reported |
|---|---|
| Chemical facts | Sequence, formula, mass and caps are verifiable. |
| General capping studies | N-acetylation protects some peptides from DPP-IV and aminopeptidases and not others. |
| Semax literature | Studies of the parent peptide in rodent and cell models; not transferable. |
| This analogue | No comparative published study of stability or activity was found. The supplier states it has not been evaluated in clinical trials. |
“Chemically plausible” is not the same as “shown”. The extended persistence expected from the caps is an untested hypothesis here.
Scientific limitations and open questions
- No published comparison with Semax was found.
- Capping can protect, fail to protect or alter activity, depending on the peptide.
- The methionine residue remains oxidation-prone, because the caps do not protect it.
- It is not approved as a medicine, and the supplier states it has not been evaluated in clinical trials.
Analytical and laboratory considerations
Mass spectrometry should show about 855.0 Da, which proves both caps are present, since Semax is 813.9 Da and a single-capped form would fall at about 812.9 Da (amide only) or 855.9 Da (acetyl only). HPLC should resolve Met-sulfoxide (+16 Da), which is the main degradation product, because methionine is exposed to light, air and heat.
See how to store peptides and the guide to reading a peptide COA. Batch reports are on the COA page, and formats are on the N-Acetyl Semax Amidate product page.
Sources and further reading
- Acetylation of peptides inhibits their degradation by rumen micro-organisms (1992). Br J Nutr 68:365-372. PubMed
- N-terminal acetylation protects glucagon-like peptide GLP-1-(7-34)-amide from DPP-IV-mediated degradation retaining cAMP- and insulin-releasing capacity (2008). PubMed
- Rational design and delivery of engineered peptides (2026 review), on terminal capping. PMC
All Baltic Peptides products are supplied strictly for laboratory research use. They are not medicines, supplements or food and are not for human or animal use. This article summarises published research for educational purposes only and does not describe any use in people.
FAQ
Common questions
What is N-Acetyl Semax Amidate?
What is the molecular weight and formula of N-Acetyl Semax Amidate?
What do the two end caps do?
Is N-Acetyl Semax Amidate more stable than Semax?
How is it different from Semax?
How is mass spectrometry used to check it?
Is N-Acetyl Semax Amidate an approved medicine?
Keep reading
Related reading
N-Acetyl Semax Amidate
Current batches, formats and the COA.
What is Semax?
The uncapped parent peptide and its research literature.
What is N-Acetyl Selank Amidate?
The same double-cap strategy applied to Selank.
Research-grade N-Acetyl Semax Amidate, tested before it ships
Independent HPLC and mass spec results for every batch, dispatched from the EU.
